Profil
Rob Slack is currently Chief Scientific Officer at Vicore Pharma Holding AB since 2026.
Formerly, Dr. Slack was Vice President & Head-Respiratory Biology at GSK Plc and Chief Scientific Officer at Damora Therapeutics, Inc. Dr. Slack earned a doctorate from the University of Strathclyde.
Aktive Positionen von Rob Slack
| Unternehmen | Position | Beginn |
|---|---|---|
| VICORE PHARMA HOLDING AB | Technik-/Wissenschafts-/F&E-Leiter | 06.07.2026 |
Ehemalige bekannte Positionen von Rob Slack
| Unternehmen | Position | Ende |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
| DAMORA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Rob Slack
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Strathclyde
University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vicore Pharma Holding AB
Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
Galecto, Inc.
Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
















